Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
SENS - Senseonics Holdings, Inc.
Market Cap 411.35M P/E - EPS this Y -18.20% Ern Qtrly Grth -
Income -80.46M Forward P/E -6.59 EPS next Y 7.70% 50D Avg Chg 7.00%
Sales 24.04M PEG 0.10 EPS past 5Y - 200D Avg Chg -8.00%
Dividend N/A Price/Book 6.40 EPS next 5Y -27.60% 52W High Chg -65.00%
Recommedations 3.00 Quick Ratio 2.74 Shares Outstanding 535.57M 52W Low Chg 59.00%
Insider Own 7.01% ROA -34.80% Shares Float 507.73M Beta 0.80
Inst Own 11.03% ROE -125.30% Shares Shorted/Prior 46.90M/43.99M Price 0.86
Gross Margin 12.04% Profit Margin - Avg. Volume 7,052,512 Target Price 1.40
Oper. Margin -400.68% Earnings Date Nov 7 Volume 5,769,068 Change -3.62%
Healthcare | Medical Devices | United States
About Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Senseonics Holdings, Inc. News
12/09/24 Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
11/12/24 Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
11/08/24 Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...
11/07/24 Senseonics Holdings (SENS) Reports Q3 Loss, Tops Revenue Estimates
11/07/24 Senseonics: Q3 Earnings Snapshot
11/07/24 Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results
10/25/24 Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering
10/24/24 Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time
10/16/24 Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
10/10/24 Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
09/24/24 Senseonics Stock Down Despite New FDA Approval for Eversense 365
09/18/24 Senseonics and Ascensia announce FDA approval for one-year CGM system
09/17/24 FDA Approves Glucose Monitor That Can Be Worn for a Year
09/17/24 Senseonics receives FDA clearance for one-year CGM
09/17/24 Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
09/06/24 Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
08/08/24 Senseonics: Q2 Earnings Snapshot
08/08/24 Senseonics Holdings, Inc. Reports Second Quarter 2024 Financial Results
08/07/24 Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Larkin Sharon Director Director Sep 07 Sell 0.61 30,889 18,842 292,476 09/08/23
ROEDER DOUGLAS A Director Director Aug 30 Buy 0.54 300,000 162,000 807,988 08/31/23
JAIN Mukul Chief Operating Offi.. Chief Operating Officer Aug 04 Sell 1.97 50,000 98,500 2,506,156 08/05/22
Fiorentino Edward Director Director Mar 11 Option 0.54 83,900 45,306 491,292 03/15/22
Fiorentino Edward Director Director Mar 11 Sell 1.65 63,553 104,862 427,739 03/15/22
Tressler Nick B. Chief Financial Offi.. Chief Financial Officer Feb 10 Sell 2.46 72,873 179,268 307,410 02/14/22
Panlilio Mirasol VP Global Sales and.. VP Global Sales and Marketing Feb 10 Sell 2.46 105,760 260,170 1,083,788 02/14/22
Kaufman Francine Chief Medical Office.. Chief Medical Officer Feb 10 Sell 2.46 163,870 403,120 1,222,175 02/14/22
JAIN Mukul Chief Operating Offi.. Chief Operating Officer Feb 10 Sell 2.46 150,197 369,485 1,849,410 02/14/22
Horton Kenneth L GC & Corp. Developme.. GC & Corp. Development Advisor Feb 10 Sell 2.46 143,126 352,090 1,217,425 02/14/22
Goodnow Timothy T President and CEO President and CEO Feb 10 Sell 2.46 464,390 1,142,399 4,737,786 02/14/22
Raab Anthony R. Director Director May 25 Sell 2.53 136,538 345,441 217,022 12/08/21
ROEDER DOUGLAS A Director Director Aug 26 Sell 3.58 341,089 1,221,099 60,483 08/26/21
ROEDER DOUGLAS A Director Director Aug 26 Option 1.66 215,747 358,140 276,230 08/26/21
JAIN Mukul Chief Operating Offi.. Chief Operating Officer Jun 16 Option 0.54 50,000 27,000 2,020,557 06/16/21
Prince Douglas S Director Director May 27 Sell 1.9 136,539 259,424 231,795 05/27/21
Fiorentino Edward Director Director May 27 Sell 1.91 109,231 208,631 333,644 05/27/21
DeFalco Stephen P Director Director May 27 Sell 2 109,231 218,462 1,169,853 05/27/21
ROEDER DOUGLAS A Director Director Apr 13 Sell 2.25 9,846,294 22,154,162 652 04/13/21